quinazolines has been researched along with Cardiac Diseases in 20 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 7 (35.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 6 (30.00) | 29.6817 |
| 2010's | 6 (30.00) | 24.3611 |
| 2020's | 1 (5.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, X; Fu, H; Gao, Z; He, Q; Jin, Y; Luo, P; Pan, Z; Wang, X; Xu, B; Xu, Z; Yan, H; Yang, B; Yang, X; Zeng, Y; Zhang, X; Zhang, Y | 1 |
| Bhuva, N; Buckley, A; Harrison, M; Kelly, C; Saunders, M | 1 |
| Lind, P; Nearchou, A; Polyzos, NP; Valachis, A | 1 |
| Hoving, S; Russell, NS; Seemann, I; Song, JY; Stewart, FA; te Poele, JA | 1 |
| Ferry, D; Fournier, M; Gebski, V; Gordon, S; Karapetis, CS; Price, TJ; Ransom, D; Simes, RJ; Tebbutt, N; Wilson, K; Yip, D | 1 |
| Patanè, S | 1 |
| Azim, H; Azim, HA; Escudier, B | 1 |
| Altundag, K; Dogan, E; Ozer, N; Ozisik, Y; Petekkaya, I; Yorgun, H | 1 |
| DALLAVOLTA, S; MASCHIO, G; POLI, D | 1 |
| GELFAND, M; WESSELS, P | 1 |
| Petrides, PE | 1 |
| Berger, M; Cameron, D; Campone, M; Chan, A; Chan, S; Crown, J; Davidson, N; Forster, J; Geyer, CE; Jagiello-Gruszfeld, A; Kaufman, B; Lindquist, D; Oliva, C; Pienkowski, T; Romieu, CG; Rubin, SD; Skarlos, D; Stein, S | 1 |
| Force, T; Krause, DS; Van Etten, RA | 1 |
| Eniu, A | 1 |
| Mukharliamov, NM | 1 |
| Goebel, R; Klein, W | 1 |
| Boland, J; Calay, G; Gillard, C | 1 |
| Chan, W; Espiner, EA; Ikram, H; Nicholls, MG | 1 |
| Hagel, KJ; Netz, H; Rautenburg, HW | 1 |
6 review(s) available for quinazolines and Cardiac Diseases
| Article | Year |
|---|---|
Use of raltitrexed as an alternative to 5-fluorouracil and capecitabine in cancer patients with cardiac history.
Topics: Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Deoxycytidine; Fluorouracil; Heart Diseases; Humans; Neoplasms; Quinazolines; Retrospective Studies; Thiophenes | 2013 |
Cardiac toxicity in breast cancer patients treated with dual HER2 blockade.
Topics: Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Female; Heart Diseases; Humans; Lapatinib; Prognosis; Quinazolines; Randomized Controlled Trials as Topic; Receptor, ErbB-2; Trastuzumab | 2013 |
Trastuzumab versus lapatinib: the cardiac side of the story.
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Breast Neoplasms; Female; Heart Diseases; Humans; Lapatinib; Quinazolines; Trastuzumab | 2009 |
Anagrelide: a decade of clinical experience with its use for the treatment of primary thrombocythaemia.
Topics: Animals; Carcinogens; Clinical Trials as Topic; Drug Therapy, Combination; Heart Diseases; Humans; Hydroxyurea; Interferon Type I; Mutagens; Platelet Aggregation Inhibitors; Platelet Count; Quinazolines; Recombinant Proteins; Thrombocythemia, Essential; Thromboembolism | 2004 |
Molecular mechanisms of cardiotoxicity of tyrosine kinase inhibition.
Topics: Adaptor Proteins, Signal Transducing; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Benzenesulfonates; Drug Delivery Systems; Enzyme Inhibitors; Heart; Heart Diseases; Humans; Indoles; Lapatinib; Models, Biological; Neoplasms; Niacinamide; Phenylurea Compounds; Protein Kinase Inhibitors; Protein-Tyrosine Kinases; Proto-Oncogene Proteins c-abl; Pyridines; Pyrroles; Quinazolines; Sorafenib; Sunitinib; Trastuzumab | 2007 |
Integrating biological agents into systemic therapy of breast cancer: trastuzumab, lapatinib, bevacizumab.
Topics: Angiogenesis Inhibitors; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Breast Neoplasms; Female; Gene Expression Regulation, Neoplastic; Genetic Testing; Heart Diseases; Humans; Lapatinib; Neoplasm Invasiveness; Neoplasm Metastasis; Neovascularization, Pathologic; Patient Selection; Protein Kinase Inhibitors; Quinazolines; Receptor, ErbB-2; Trastuzumab; Treatment Outcome; Vascular Endothelial Growth Factor A | 2007 |
1 trial(s) available for quinazolines and Cardiac Diseases
| Article | Year |
|---|---|
Lapatinib plus capecitabine for HER2-positive advanced breast cancer.
Topics: Adult; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Capecitabine; Deoxycytidine; Disease Progression; Female; Fluorouracil; Heart Diseases; Humans; Lapatinib; Middle Aged; Proportional Hazards Models; Protein Kinase Inhibitors; Quinazolines; Receptor, ErbB-2; Survival Analysis | 2006 |
13 other study(ies) available for quinazolines and Cardiac Diseases
| Article | Year |
|---|---|
PTX3 from vascular endothelial cells contributes to trastuzumab-induced cardiac complications.
Topics: Animals; Antibodies, Monoclonal; Antineoplastic Agents; Breast Neoplasms; Calcium; Cardiotoxicity; Endothelial Cells; Female; Heart Diseases; Humans; Induced Pluripotent Stem Cells; Lapatinib; Mice; Quinazolines; Rats; Receptor, ErbB-2; Trastuzumab | 2023 |
Radiation- and anthracycline-induced cardiac toxicity and the influence of ErbB2 blocking agents.
Topics: Animals; Antibiotics, Antineoplastic; Antibodies, Monoclonal, Humanized; Cell Survival; Cells, Cultured; Coronary Vessels; Doxorubicin; Fibrosis; Heart Diseases; Humans; Lapatinib; Male; Mice; Mice, Inbred C57BL; Microvessels; Mitochondria, Heart; Myocardium; Myocytes, Cardiac; Pericardium; Quinazolines; Radiation Injuries, Experimental; Receptor, ErbB-2; Trastuzumab; Ventricular Function, Left | 2013 |
Final results of Australasian Gastrointestinal Trials Group ARCTIC study: an audit of raltitrexed for patients with cardiac toxicity induced by fluoropyrimidines.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Capecitabine; Colorectal Neoplasms; Deoxycytidine; Drug Substitution; Fluorouracil; Heart Diseases; Humans; Irinotecan; Middle Aged; Quinazolines; Thiophenes | 2014 |
Is there a role for quinazoline-based α (1)-adrenoceptor antagonists in cardio-oncology?
Topics: Adrenergic alpha-1 Receptor Antagonists; Heart Diseases; Humans; Medical Oncology; Neoplasms; Quinazolines; Receptors, Adrenergic | 2014 |
Evaluation of cardiac safety of lapatinib therapy for ErbB2-positive metastatic breast cancer: a single center experience.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Breast Neoplasms; Female; Genes, erbB-2; Heart; Heart Diseases; Humans; Incidence; Lapatinib; Middle Aged; Quinazolines; Receptor, ErbB-2 | 2012 |
[CLINICAL RESEARCH ON A NEW QUINAZOLINIC DIURETIC].
Topics: Biomedical Research; Diuretics; Heart Diseases; Natriuresis; Pharmacology; Quinazolines; Sulfonamides; Toxicology | 1964 |
ACANTHOCHEILONEMA PERSTANS IN A EUROPEAN FEMALE. A DISCUSSION OF ITS POSSIBLE PATHOGENICITY AND A SUGGESTED NEW SYNDROME.
Topics: Acanthocheilonema; Animals; Ascites; Betamethasone; Biopsy; Diethylcarbamazine; Dipetalonema; Drug Therapy; Female; Filariasis; Heart Diseases; Humans; Liver Diseases; Mansonella; Quinazolines; Sulfonamides; Toxicology; Virulence; White People; Zimbabwe | 1964 |
Expect the unexpected.
Topics: Animals; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Gefitinib; Heart Diseases; Humans; Multiple Organ Failure; Neoplasms; Pneumonia; Quinazolines | 2006 |
[Effect on the peripheral circulation during treatment of cardiac insufficiency].
Topics: Blood Circulation; Cardiac Output; Heart; Heart Diseases; Hemodynamics; Humans; Nitrates; Nitroglycerin; Nitroprusside; Oxygen Consumption; Phentolamine; Piperazines; Prazosin; Quinazolines; Vascular Resistance; Vasodilator Agents | 1980 |
[Effects of acute and chronic vasodilator administration on hemodynamics and catecholamine concentration in chronic left heart failure (author's transl)].
Topics: Blood Pressure; Cardiac Output; Cardiomyopathies; Catecholamines; Coronary Disease; Dopamine; Epinephrine; Heart Diseases; Heart Failure; Hemodynamics; Humans; Hypertension; Male; Middle Aged; Nitroglycerin; Norepinephrine; Physical Exertion; Prazosin; Quinazolines; Vascular Resistance | 1980 |
[Short- and medium-term hemodynamic effects of prazosin in chronic refractory cardiac failure].
Topics: Adult; Aged; Female; Heart Diseases; Hemodynamics; Humans; Male; Middle Aged; Prazosin; Quinazolines; Time Factors | 1982 |
A possible mechanism for "tachyphylaxis' to prazosin in heart failure.
Topics: Angiotensin II; Heart Diseases; Hemodynamics; Humans; Prazosin; Quinazolines; Renin; Tachycardia | 1980 |
[Initial results of prazosin in the treatment of severe heart insufficiencies in children].
Topics: Adolescent; Child; Child, Preschool; Heart Diseases; Humans; Infant; Prazosin; Quinazolines | 1982 |